Recently, Infor and HARMAN International, a wholly-owned subsidiary of Samsung Electronics Co. Ltd., announced a global strategic partnership. This partnership will allow healthcare and life sciences organizations to modernize their data platforms, strategies, and roadmaps through customer-centric services and solutions. Per the press release, HARMAN and Infor will deliver a jointly developed integrated healthcare platform — built on the cloud — that will help industry clients seamlessly transform data, analytics, intelligence, and governance functions in a secure, cost-effective, and privacy preserving manner. Additionally, through the Infor Cloverleaf Integration Suite, HARMAN artificial intelligence and machine learning (AI/ML) algorithms securely process both structured and unstructured data extracted from databases, interface engines, and CDA XML (clinical document architecture extensible markup language) documents. The HARMAN IHP output is then integrated back into existing provider systems (e.g., electronic health records (EHRs), etc.) to offer a host of benefits including predicting readmission or attrition risks, providing transparency into payer systems to help predict and detect claims fraud, and assisting with intelligent document processing. Further, the integration also enables enhanced video monitoring, allowing one nurse to monitor multiple patients beyond vitals; this includes unusual movements (i.e., spasms post-surgery).